beginner7 min read

What Are Nootropics? A Complete Beginner Guide

Everything you need to know before taking your first nootropic supplement — what they are, how they differ from stimulants, and what the evidence actually says.

The definition

The term "nootropic" was coined in 1972 by Romanian psychologist Corneliu Giurgea, who defined nootropics as substances that enhance learning and memory, protect the brain from injury, increase the efficacy of cortical and subcortical control mechanisms, and have no sedative or stimulant effects. Modern usage is broader: nootropics now refers to any supplement, drug, or compound taken with the goal of enhancing cognitive function — including memory, focus, creativity, motivation, or mental clarity.

Nootropics vs. stimulants

Stimulants (caffeine, modafinil, Adderall) produce short-term performance boosts primarily by increasing catecholamine release — but often at the cost of rebound fatigue, dependency, and disrupted sleep. True nootropics, by Giurgea's original criteria, should enhance cognition without producing significant stimulant effects or withdrawal. Most modern supplements fall in between: they combine stimulant and nootropic ingredients to deliver both acute and long-term benefits. Understanding this distinction helps you set realistic expectations.

Types of nootropics

Nootropic supplements fall into several categories: (1) Adaptogens (Ashwagandha, Rhodiola Rosea) — reduce stress hormones and support cognitive resilience under pressure. (2) Cholinergics (Citicoline, Alpha-GPC, Huperzine A) — support acetylcholine synthesis or inhibit its breakdown; important for memory and learning. (3) Racetams (Piracetam, Aniracetam) — synthetic compounds that modulate glutamate receptors; available OTC in some countries, prescription-only in others. (4) Mushrooms (Lion's Mane, Reishi) — stimulate NGF (Nerve Growth Factor) and support neurogenesis. (5) Amino acids (L-Theanine, L-Tyrosine) — precursors to neurotransmitters; the most studied and safest category.

What the science actually shows

The honest answer: the evidence varies enormously by ingredient. L-Theanine paired with caffeine has robust acute RCT evidence for calm focus. Bacopa Monnieri has strong evidence for memory consolidation over 8–12 weeks. Lion's Mane has promising but limited human trial data for long-term neuroprotection. Many products on the market combine clinically-backed ingredients at sub-clinical doses with well-marketed but under-studied compounds. The single most important question to ask about any nootropic is: what dose of each ingredient is in this formula, and does it match what was used in clinical trials?

Are nootropics safe?

Most mainstream nootropic supplements use food-grade or well-studied ingredients at doses considered safe for healthy adults. However, "natural" does not mean risk-free. Some ingredients interact with medications (e.g. Huperzine A with cholinesterase inhibitors, Rhodiola with MAO inhibitors). A few ingredients carry regulatory restrictions in certain countries. Always consult a qualified healthcare professional before starting any supplement, especially if you take prescription medications or have a pre-existing health condition.

Nootropics in the EU

In the EU, nootropic supplements sold as food supplements fall under Directive 2002/46/EC, which defines that category. EU Directive 2002/46/EC defines this category as "food supplements" -- concentrated sources of nutrients or other substances sold in dose form such as capsules or tablets. That status shapes what a label may say: any statement linking an ingredient to a health effect is a "health claim" under Regulation (EC) 1924/2006 and can only appear if it has been authorised. A separate check, the EU novel-food regime, can also apply to newer or unconventional ingredients before they may be sold at all.

Sold as a food supplement, not a medicine

Directive 2002/46/EC defines "food supplements" as "foodstuffs the purpose of which is to supplement the normal diet and which are concentrated sources of nutrients or other substances with a nutritional or physiological effect, alone or in combination, marketed in dose form" such as capsules, tablets or drop bottles (Article 2(a)). A capsule or tablet product that fits this definition and is not a medicinal product is regulated as food, and its label must use the term "food supplement" under the Directive's Article 6(1).

What a label is allowed to claim

Regulation (EC) 1924/2006 defines a "health claim" as "any claim that states, suggests or implies that a relationship exists between a food category, a food or one of its constituents and health" (Article 2(2)(5)). Under Article 10(1), "health claims shall be prohibited unless they comply with the general requirements in Chapter II and the specific requirements in this Chapter and are authorised in accordance with this Regulation." This is why EU nootropic listings avoid unauthorised claims about mood, memory or cognition, and Directive 2002/46/EC additionally bars labelling that attributes to a supplement "the property of preventing, treating or curing a human disease" (Article 6(2)).

Products in the EU

EU food supplement (Reg. 1924/2006 claims)

Are nootropics classed as medicines in the EU?

Not when sold as supplements. A product that meets the Directive 2002/46/EC definition of "food supplements," described as "foodstuffs the purpose of which is to supplement the normal diet" and sold in dose form (Article 2(a)). Being regulated as food rather than as a medicinal product is a legal classification, not a claim about what any specific product does.

Can an EU listing say a nootropic boosts memory or focus?

Only if that statement is an authorised health claim. Regulation (EC) 1924/2006 provides that "health claims shall be prohibited unless" they are "authorised in accordance with this Regulation and included in the lists of authorised claims" (Article 10(1)). An unauthorised cognitive-benefit statement on an EU label or listing would not be compliant.

Does every nootropic ingredient need special EU approval?

It depends on the ingredient. Under Regulation (EU) 2015/2283, "only novel foods authorised and included in the Union list may be placed on the market within the Union" (Article 6(2)), and "novel food" is defined to include foods with new production processes or without a significant history of consumption in the EU before 15 May 1997 (Article 3(2)(a)). Ingredients that qualify as novel food need that authorisation before sale; long-established ones typically do not.

EU country guides

Sources: Directive 2002/46/EC, Article 2(a) -- definition of food supplements · Directive 2002/46/EC, Article 6 -- naming and disease-claim prohibition · Regulation (EC) 1924/2006, Article 2(2)(5) -- definition of health claim · Regulation (EC) 1924/2006, Article 10(1) -- health claims prohibited unless authorised · Regulation (EU) 2015/2283, Article 3(2)(a) -- definition of novel food · Regulation (EU) 2015/2283, Article 6(2) -- only authorised novel foods may be marketed

Regulatory note

Cognitive-effect language on this page describes ingredient mechanisms studied in clinical trials. Health claims on supplements sold in the EU are governed by Regulation (EC) No 1924/2006; only European Food Safety Authority (EFSA) approved claims may appear on product labelling. This page is editorial, not promotional, and does not constitute medical advice. Consult a qualified healthcare professional before starting any supplement.

← Back to Guides